Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Local Neoplasm Recurrence. Found 103 abstracts

no pagination
Lee Z, Jegede OA, Haas NB, Pins MR, Messing EM, Manola J, Wood CG, Kane CJ, Jewett MA, Flaherty KT, Dutcher JP, DiPaola RS, Uzzo RG. Local Recurrence Following Resection of Intermediate-High Risk Nonmetastatic Renal Cell Carcinoma: An Anatomical Classification and Analysis of the ASSURE (ECOG-ACRIN E2805) Adjuvant Trial. J Urol. 2020 Apr;203(4):684-9.
Churilla TM, Chowdhury IH, Handorf E, Collette L, Collette S, Dong Y, Alexander BM, Kocher M, Soffietti R, Claus EB, Weiss SE. Comparison of Local Control of Brain Metastases With Stereotactic Radiosurgery vs Surgical Resection: A Secondary Analysis of a Randomized Clinical Trial. JAMA Oncol. 2019 Feb;5(2):243-7.   PMCID: PMC6439566
Cohen EE, Soulieres D, Le Tourneau C, Dinis J, Licitra L, Ahn MJ, Soria A, Machiels JP, Mach N, Mehra R, Burtness B, Zhang P, Cheng J, Swaby RF, Harrington KJ. Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study. Lancet (London, England). 2019 Jan 12;393(10167):156-67.
Lee Z, Jegede OA, Haas NB, Pins MR, Messing EM, Manola J, Wood CG, Kane CJ, Jewett MA, Flaherty KT, Dutcher JP, DiPaola RS, Uzzo RG. Local Recurrence Following Resection of Intermediate-High Risk Non-metastatic Renal Cell Carcinoma: An Anatomic Classification and Analysis of the ASSURE (ECOG-ACRIN E2805) Adjuvant Trial. J Urol. 2019 Oct 09;:101097ju0000000000000588.
Bartel MJ, Puri R, Brahmbhatt B, Chen WC, Kim D, Simons-Linares CR, Stauffer JA, Buchanan MA, Bowers SP, Woodward TA, Wallace MB, Raimondo M, Asbun HJ. Endoscopic and surgical management of nonampullary duodenal neoplasms. Surgical endoscopy. 2018 Jun;32(6):2859-69.
Lamb EP, Pritchard FE, Nouer SS, Tolley EA, Boyd BS, Davidson JT, Munene G, Fleming MD. Understanding Disparities in Breast Cancer Care in Memphis, Tennessee. Am Surg. 2018 May;84(5):620-7.
Mehra R, Seiwert TY, Gupta S, Weiss J, Gluck I, Eder JP, Burtness B, Tahara M, Keam B, Kang H, Muro K, Geva R, Chung HC, Lin CC, Aurora-Garg D, Ray A, Pathiraja K, Cheng J, Chow LQ, Haddad R. Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012. Br J Cancer. 2018 Jul;119(2):153-9.   PMCID: PMC6048158
von Mehren M, Joensuu H. Gastrointestinal Stromal Tumors. J Clin Oncol. 2018 Jan 10;36(2):136-43.   PMCID: PMC6553810
Arthur DW, Winter KA, Kuerer HM, Haffty BG, Cuttino LW, Todor DA, Simone NL, Hayes SB, Woodward WA, McCormick B, Cohen RJ, Sahijdak WM, Canaday DJ, Brown DR, Currey AD, Fisher CM, Jagsi R, White J. NRG Oncology-Radiation Therapy Oncology Group Study 1014: 1-Year Toxicity Report From a Phase 2 Study of Repeat Breast-Preserving Surgery and 3-Dimensional Conformal Partial-Breast Reirradiation for In-Breast Recurrence. Int J Radiat Oncol Biol Phys. 2017 Aug;98(5):1028-35.   PMCID: PMC5572128
Coleman RL, Brady MF, Herzog TJ, Sabbatini P, Armstrong DK, Walker JL, Kim BG, Fujiwara K, Tewari KS, O'Malley DM, Davidson SA, Rubin SC, DiSilvestro P, Basen-Engquist K, Huang H, Chan JK, Spirtos NM, Ashfaq R, Mannel RS. Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2017 Jun;18(6):779-91.   PMCID: PMC5715461
Jordan SE, Micaily I, Hernandez E, Ferriss JS, Miyamoto CT, Li S, Micaily B. Image-guided high-dose-rate intracavitary brachytherapy in the treatment of medically inoperable early-stage endometrioid type endometrial adenocarcinoma. Brachytherapy. 2017 Nov;16(6):1144-51.
Jordan SE, Micaily I, Hernandez E, Ferriss JS, Miyamoto CT, Li S, Micaily B. Image-guided high-dose-rate intracavitary brachytherapy in the treatment of medically inoperable early-stage endometrioid type endometrial adenocarcinoma. Brachytherapy. 2017 Nov;16(6):1144-51.
Pickhardt PJ, Edwards K, Bruining DH, Gollub M, Kupfer S, Lubner SJ, Kim DH, Ross E, Keenan E, Weinberg DS. Prospective Trial Evaluating the Surgical Anastomosis at One-Year Colorectal Cancer Surveillance: CT Colonography Versus Optical Colonoscopy and Implications for Patient Care. Diseases of the colon and rectum. 2017 Nov;60(11):1162-7.   PMCID: PMC5635837
Wang LS, Handorf EA, Wu H, Liu JC, Perlis CS, Galloway TJ. Surgery and Adjuvant Radiation for High-risk Skin Adnexal Carcinoma of the Head and Neck. Am J Clin Oncol. 2017 Aug;40(4):429-32.   PMCID: PMC4504824
Xu MJ, Chu C, Rubin S, Lin LL. Survival Outcomes Improved in Contemporary Cohort of Patients With Pelvic or Abdominal Recurrence After Treatment for Stage I/II Endometrial Carcinoma. Am J Clin Oncol. 2017 Dec;40(6):598-604.   PMCID: PMC4733581
Beitler JJ, Quon H, Jones CU, Salama JK, Busse PM, Cooper JS, Koyfman SA, Ridge JA, Saba NF, Siddiqui F, Smith RV, Worden F, Yao M, Yom SS, Expert Panel on Radiation Oncology H, Neck. ACR Appropriateness Criteria((R)) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas. Head & neck. 2016 Sep;38(9):1299-309.
Chesney TR, Nadler A, Acuna SA, Swallow CJ. Outcomes of resection for locoregionally recurrent colon cancer: A systematic review. Surgery. 2016 Jul;160(1):54-66.
Chow LQ, Haddad R, Gupta S, Mahipal A, Mehra R, Tahara M, Berger R, Eder JP, Burtness B, Lee SH, Keam B, Kang H, Muro K, Weiss J, Geva R, Lin CC, Chung HC, Meister A, Dolled-Filhart M, Pathiraja K, Cheng JD, Seiwert TY. Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort. J Clin Oncol. 2016 Nov 10;34(32):3838-45.
Guttmann DM, Li H, Sevak P, Grover S, Jacobson G, Feldman A, Rubin S, Chu C, Bhatia S, Elshaikh MA, Lin LL. The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2016 Jan;26(1):141-8.
Hossain NM, Klumpp T, Ulicny J, Garner M, Kropf PL, Mangan KF, Barta SK, Fung HC, Martin ME. Donor Lymphocyte Infusion in Hematologic Malignancies--Good to be Fresh?. Clinical lymphoma, myeloma & leukemia. 2016 Feb;16(2):111-5.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Local Neoplasm Recurrence

Local Neoplasm Recurrence Aged Middle Aged Female 80 and over Aged Adult pathology Male surgery mortality methods therapy Follow-Up Studies Retrospective Studies adverse effects Disease-Free Survival therapeutic use diagnostic imaging administration & dosage Squamous Cell Carcinoma of Head and Neck Survival Rate Antineoplastic Combined Chemotherapy Protocols Head and Neck Neoplasms drug therapy Brachytherapy Neoplasm Staging Prospective Studies Adjuvant Radiotherapy Monoclonal Antibodies-Humanized Young Adult Combined Modality Therapy Risk Assessment Endometrioid Carcinoma Prognosis Endometrial Neoplasms radiotherapy Tumor Burden X-Ray Computed Tomography Computer-Assisted Radiotherapy Planning Neoplasm Metastasis Intraductal Carcinoma-Noninfiltrating classification Neoplasm Invasiveness Paclitaxel genetics Endometrial cancer Treatment Outcome Computer assisted dosimetry calculations Three-Dimensional Imaging Radiotherapy Dosage Renal Cell Carcinoma Chemoradiotherapy epidemiology Neck Dissection Disease Progression Hysterectomy Adenoma Carcinosarcoma Breast Neoplasms Cohort Studies secondary Ultrasonography Endometrioid adenocarcinoma Kaplan-Meier Estimate Lymph Node Excision Intracavitary brachytherapy diagnosis Carboplatin Adjuvant Chemotherapy Nephrectomy Squamous Cell Carcinoma Magnetic Resonance Imaging B7-H1 Antigen Colon Rectum Hematologic Neoplasms Classification Length of Stay Registries Lymphocyte Transfusion Randomized Controlled Trials as Topic Fibrosis Endoscopic Mucosal Resection Radiation Oncology Adnexal and Skin Appendage Neoplasms biosynthesis drug effects Aftercare adverse Health Status Disparities Brain Neoplasms Colonic Neoplasms Neoplastic Gene Expression Regulation local Bevacizumab Phase III Clinical Trials as Topic Radiotherapy Pharyngectomy statistics & numerical data Practice Guidelines as Topic effects Reoperation Papillomavirus Infections Kidney Neoplasms Gastrointestinal Stromal Tumors European Continental Ancestry Group Methotrexate Adolescent Neoplasm Drug Resistance African Americans radiation effects Protein Kinase Inhibitors carcinoma Cytoreduction Surgical Procedures Sorafenib Postoperative Complications Abdominal Neoplasms Surgical Blood Loss Endoscopic resection Re-Irradiation Cetuximab Risk Factors Neurosurgical Procedures Delphi Technique Gastrointestinal Neoplasms Conformal Radiotherapy Operative Time Immunological Antineoplastic Agents Glandular and Epithelial Neoplasms Peritoneal Neoplasms Organ Sparing Treatments Kidney antagonists & inhibitors Multicenter Studies as Topic Neoplasm Grading Medical Societies Pelvic Neoplasms Logistic Models Donor lymphocyte infusion (DLI) Cystic Neoplasms-Mucinous-and Serous neoplasm recurrence ethnology Docetaxel Time Factors Drug Administration Schedule Breast Carcinoma In Situ Skin Overall survival Progression-Free Survival Proto-Oncogene Proteins c-kit
Last updated on Saturday, July 04, 2020